Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qidongyixin oral liquid for chemotherapy-related heart qi deficiency in cancer
ChiCTR-IPR-17010752Phase 4Not yet recruiting
- Sponsor
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
- Start
- Mar 2017
- Countries
- 1
01
Overview
Phase 4 trial of Qidongyixin oral liquid in cancer (2 arms), sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Primary endpoints: palpitations, shortness of breath and 3 more. Planned start Mar 2017; status: not yet recruiting.
02
Drugs
Qidongyixin oral liquid
03
Conditions
cancer
Beyond the preview
Go deeper on ChiCTR-IPR-17010752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17010752.